Global Life Sciences BD & Strategic Partnerships Leader

KONSTANTINE HARALAMPOPOULOS

+1-312-***-**** *********@*****.*** LinkedIn

Dual USA + European Union Life Sciences Business Development Executive Commercial Strategy Strategic Partnerships Diagnostics AI Drug Discovery CDMO CRO Biologics Cell & Gene Therapy Global pharmaceutical business development executive with 20+ years of experience driving commercial growth, strategic partnerships, licensing, AI-enabled drug discovery and contract development opportunities across North America and Europe. Proven record of building multimillion-dollar business pipelines, leading complex negotiations, expanding market presence and developing long-term relationships with pharmaceutical, biotechnology and life sciences organizations Individual Contributor and Team Leader

Reputation Resilience Relationships Results

Professional Experience

DEEP INTELLIGENT PHARMA (JAN 2026 – JUN 2026) EUROPE Director Global Business Development (Six Month Strategic Contract) for Artificial Intelligence (AI) based Start-Up Spearheaded global sales enablement initiatives that generated a qualified commercial pipeline exceeding $2,000,000 Established strategic relationships with pharmaceutical and biotechnology executives across Europe and North America FRESENIUS KABI (SEP 2024 – MAY 2025) USA / EUROPE

Senior Global Business Development Manager (Interim Executive for CDMO Business Unit) Individual Contributor focused primarily on Monoclonal Antibodies (mAbs) and Antibody Drug Conjugates (ADC)

• Won $11,500,000 in development contracts leading to projected $94,000,000 commercial manufacturing revenue

• In 8 months: Signed-Off on 11 CDAs. 5 ADC Prospect Tour Visits. Collaborated with Alliance Mangement on 4 Opportunities LEAVE OF ABSENCE (JUL 2023 – AUG 2024) Caretaker for Parents CENTER FOR BREAKTHROUGH MEDICINES (JUN 2022 – JUN 2023) USA Director Global Business Development (Selected to commercialize Cell & Gene Therapy CDMO during leadership transition) Led client engagement for AAV based Gene Therapy Programmes to support clinical and commercial manufacturing milestones

• Built and led the North American commercial organization by recruiting, onboarding and mentoring two Business Development Managers

• Sales Pipeline: $26,000,000 proposals within 12 months / Secured two gene therapy programmes worth $1,800,000 DAICEL (JAN 2020 – MAR 2022) USA / FRANCE

Director Global Business Development (Recruited to launch cGMP CRO for 24 Month engagement) Medical Device and Small / Large Molecule (Biologics) GMP Analytical Testing

• Secured $10,00,000 for Medtech, Pharma, BioPharma. Sold Actranza (In-House Developed COVID Vaccine Autoinjector)

• Injectables, Inhalation, Infusion, Transdermal, Solid Oral Dose, Topicals, Vaccines and Ocular Drug Delivery

• Developed competitive intelligence strategy to identify high-value pharmaceutical and medical device opportunities SGS (JAN 2017 – DEC 2019) USA / EUROPE

Director Business Development

Small / Large Molecule (Biologics) and Medical Device cGMP CRO

• Managed varierty of accounts supporting clinical through commercial product development

• 2019: Closed Largest Deal ($2,300,000) / Exceeded $9,000,000 Revenue Target HENKEL (JAN 2010 – DEC 2016) GERMANY

Global Key Account Manager (GKAM)

Commercialized medical-grade adhesive technologies supporting injectable drug delivery systems, catheters, IV bags and medical devices for global healthcare manufacturers

• 2016: €26,000,000 Sales Pipeline (+26% Target) Derived From Injectable, Catheters, IV Bag Bonding Applications

• 2014: Secured BD Sustainability Vendor of the Year Award

• Co-Managed Six Regional Managers Across Five Continents. Developed Distributor Partnerships: LATAM, APAC, EMEA JOHNSON & JOHNSON (JAN 2004 – DEC 2009) USA

District Manager (Pricara Business Unit)

Led launch of multiple specialty pharmaceutical and medical technology products while managing a high-performing district sales organization

• Launched PillCam (Diagnostic MedTech) and Ultram ER and managed 10 direct reports

• MAR 2009 Ranked: District: 1/9 Region: 2/94 Largest Leaper Award Recipient (2005) and Presidents Club (2008-2009)

• Call Points: Dermatology, Neurology, Orthopedics, Infectious Disease, Pulmonology, Urology, Nephrology, Women’s Health, Emergency Medicine, Wound Care, ENT, Gastroeterology KONFIDANT (JAN 1996 – DEC 2003) USA / EUROPE

Founder Commercial Strategy & Life Sciences Consulting Served First Mover Medical Products and Services for Early Adopter Clients Noteworthy Key Takeaway Client Project Achievements Include: Pioneer for Disruptive First Mover Point-of-Care Technology Established Advanced Pain Treatment Centers as Global Best-in-Class Pain Medicine Treatment Practice

• Created $15,000,000 Valuation of Minimally Invasive Launch and Sale

• Coordinated RWD / RWE Clinical Study Resulting in 320% Increase Commercial Insurance Payer Reimbursements

• Opened three Clinical Sites Including EU. Annual P&L Responsibility Exceeding $5,000,000

• Referral Sources: Orthopedics, Oncology, Psychiatry, Neurology, Rheumatology for Spinal and Migraine Conditions Launched Diabetes Risk Assessment: Class II In Vitro Diagnostic (IVD) Lateral Flow Assay for Glycemion

• Selected as First-Line Go To Market Screen for Type 2 Diabetes by Harvard School of Dental Medicine

• Secured Private label OTC Distribution Deal ($5,000,000) to Ophthalmologists, Dentists and Primary Care Physicians Upstream Marketing and Sales Support to GE Healthcare Diagnostic Imaging Capital Equipment

• Provided Next-Gen Enhancement Recommendations for Fluoroscopy (C-Arm) Re-Launch

• Represented GE Healthcare at Radiology Trade Shows and Conferences Over 2 Year Period

• Direct efforts resulted in a +9% YTY Market Share Penetration for Re-Furbished Purchase Orders ($4,200,000) Education

UNIVERSITY OF CHICAGO, MBA, Booth Graduate School of Business

• Summer Rotational Internship: Citibank Greece (Finance, Marketing, Investment Banking and Retail Banking) UNIVERSITY OF ILLINOIS, Bachelor’s of Science, Biological Sciences

• Research Assistant Genetics Department / Athletics Scholarship Additional Information

• Adjunct Professor, University of St Francis (Healthcare Business Strategy / Marketing Courses)

• Distinguished Allscripts (SaaS) Continuing Medical Education (CME) Panelist & Key Note Speaker: EMR Coding Billing Healthcare IT ( PACS / RIS / EHR) Payer Reimbursement Negotiation

• Native Speaker: Greek / English. Working Knowledge: Spanish

• Certifications: Herman-Miller Scotwork Negotiation Getting to Yes EQ: Cross Cultural Mapping

• Dual Citizen and Resident USA / European Union (EU)

Contact this candidate